Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Comparison of dominant fund strategies for retirement, weighing SP 500 versus Total Market to guide your decision.
28,607 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
An experienced investment banker explains why pension funds stick with complex alternatives even when a simple 60/40 ...
A fresh purchase adds 3,015 BTC for about $204.1 million, lifting total holdings to 720,737 BTC. BTC sits near $66,00...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...
The Army announces a framework allowing private funds to finance and operate base infrastructure, signaling a major s...
Bank of America lifts Micron Technology's price target to $950, arguing a larger AI data-center market drives sustain...
A U.S. startup says its graphene-based, non-lithium energy storage solution is safer and faster to deploy, reporting ...
SpaceX captures imagination and investors. But before you rush to buy, weigh the risks, liquidity, and market dynamic...